## Abstract Dynamic contrast‐enhanced MRI (DCE‐MRI) is frequently used to provide response biomarkers in clinical trials of novel cancer therapeutics but assessment of their physiological accuracy is difficult. DCE‐CT provides an independent probe of similar pharmacokinetic processes and may be mod
Dynamic contrast-enhanced MRI in clinical trials of antivascular therapies
✍ Scribed by O'Connor, James P. B.; Jackson, Alan; Parker, Geoff J. M.; Roberts, Caleb; Jayson, Gordon C.
- Book ID
- 118068902
- Publisher
- Nature Publishing Group
- Year
- 2012
- Tongue
- English
- Weight
- 932 KB
- Volume
- 9
- Category
- Article
- ISSN
- 1759-4774
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract The spatial resolution of three‐dimensional (3D) gradient‐echo T1‐weighted images, from 40 women with 25 malignant and 23 benign lesions, was purposely degraded to determine the role of spatial resolution in recording, analysis, and diagnosis of dynamic contrast‐enhanced breast MRI. Ima
## Abstract In previous papers relative signal intensity increase was used as a quantitative assessment parameter for contrast uptake in contrastenhanced MRI. However, relative signal intensity increase does not only reflect contrast uptake but depends also on tissue parameters (native __T__~1~ rel